Langlara - Drug Details
๐Ÿ“Š Estimates Langlara Dialyzability By Different_Modalities

Langlara

Complete Drug Information

Drug Name
Langlara
Trade Names
Lantus
Pregnancy Category
AU: B3
Routes of Administration
Subcutaneous
Formula
C267H404N72O78S6
Molar Mass
6062.96
Onset of Action
1 hour
Duration of Action
24โ€“36 hours
Volume of Distribution
C267H404N72O78S6

๐Ÿคฐ Pregnancy Category Information

Category: AU: B3

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans.